2Edwards JL,Vincent AM,Cheng HT,et al.Diabetic neuropathy:mechanisms to management[J].Pharmacol Ther,2008,120(1):1-34.
3The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J].N Engl J Med,1993,329(14)::977-986.
4Martin CL,Albers J,Herman WH,et al.Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion[J].Diabetes Care,2006,29(2):340-344.
5Cameron N,Cotter M,Inkster M,et al.Looking to the future:diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models[J].Diabetes Res Clin Pract,2003,61(Suppl 1):S35-39.
6Leiter LA.The prevention of diabetic microvascular complications of diabetes:is there a role for lipid lowering?[J].Diabetes Res Clin Pract,2005,68(Suppl 2):S3-14.
7Gordon SA,Robinson SJ.Idiopathic neuropathy,prediabetes and the metabolic syndrome[J].J Neurol Sci,2006,242(1-2):9-14.
8UK Prospective Diabetes Study Group,Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38[J].BMJ,1998,317(7160):703-713.
9I.M.Stratton,A.I.Adler,H.A.Neil,et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35):prospective observational study[J].BMJ,2000,321(7258):405-412.
10Diabetes Control and Complications Trial Cohort.Epidemiology of Diabetes Interventions and Complications (EDIC).Design,implementation,and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort[J].Diabetes Care,1999,22(1):99-111.
